It's just a scoping study, I don't think the market has put any value on Nymagee anyway so if the study comes back as a dud it will have no effect on share price but it won't be vice versa and may even attract a JV partner to that project
The fact that the company has the head space to consider the scoping study is further evidence that the problems of past are behind them.
I can't see any reason why this stock won't stabilise at 35c in the short term
Ann: Nymagee Scoping Study Commences, page-13
Add AMI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $355.2M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.5¢ | $357.4K | 1.722M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 121951 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 888884 | 20 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| AMI (ASX) Chart |